Evidence map›Paper›PMID 31487797›Full record

Trial reportNutrients2019

Effects of Regular Kefir Consumption on Gut Microbiota in Patients with Metabolic Syndrome: A Parallel-Group, Randomized, Controlled Study.

Ezgi Bellikci-Koyu, Banu Pınar Sarer-Yurekli, Yakut Akyon, Fadime Aydin-Kose, Cem Karagozlu, Ahmet Gokhan Ozgen, Annika Brinkmann, Andreas Nitsche, Koray Ergunay, Engin Yilmaz and 1 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 8 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 8 syntheses or guidelines pooled it, 136 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Ezgi Bellikci-KoyuDepartment of Nutrition and Dietetics, Faculty of Health Sciences, Hacettepe University, Ankara 06230, Turkey.ORCID 0000-0001-5279-2394
Banu Pınar Sarer-YurekliDepartment of Endocrinology, Faculty of Medicine, Ege University, Izmir 35040, Turkey.
Yakut AkyonDepartment of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara 06230, Turkey.
Fadime Aydin-KoseDepartment of Biochemistry, Faculty of Pharmacy, Ege University, Izmir 35040, Turkey.ORCID 0000-0001-5222-7555
Cem KaragozluDepartment of Dairy Technology, Faculty of Agriculture, Ege University, Izmir 35040, Turkey.ORCID 0000-0002-2874-4998
Ahmet Gokhan OzgenDepartment of Endocrinology, Faculty of Medicine, Ege University, Izmir 35040, Turkey.
Annika BrinkmannRobert Koch Institute; Center for Biological Threats and Special Pathogens 1 (ZBS-1), Berlin 13353, Germany.
Andreas NitscheRobert Koch Institute; Center for Biological Threats and Special Pathogens 1 (ZBS-1), Berlin 13353, Germany.
Koray ErgunayDepartment of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara 06230, Turkey.
Engin YilmazDepartment of Medical Biology, Acıbadem Mehmet Ali Aydınlar University, Istanbul 34752, Turkey.
Zehra BuyuktuncerDepartment of Nutrition and Dietetics, Faculty of Health Sciences, Hacettepe University, Ankara 06230, Turkey. zbtuncer@hacettepe.edu.tr.
Ege University · TRHacettepe University · TRRobert Koch Institute · DEIzmir Kâtip Çelebi University · TRKent Hastanesi · TR

Funding

Turkish Council of Higher Education XX
6 · The paper itself

Abstract

Several health-promoting effects of kefir have been suggested, however, there is limited evidence for its potential effect on gut microbiota in metabolic syndrome This study aimed to investigate the effects of regular kefir consumption on gut microbiota composition, and their relation with the components of metabolic syndrome. In a parallel-group, randomized, controlled clinical trial setting, patients with metabolic syndrome were randomized to receive 180 mL/day kefir (

Indexed as

KefirAdolescentAdultAgedBlood GlucoseBody WeightFemaleGastrointestinal MicrobiomeHumansLipidsMaleMetabolic SyndromeMiddle AgedPhylogenyYoung AdultBlood GlucoseLipidsgut microbiotakefirmetabolic syndrome

Identifiers

PMID31487797
PMCPMC6769690
OpenAlexW2971933675

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.